Left Atrial Appendage Closure Devices Market

The left atrial appendage closure devices market was valued at USD 503.7 Mn by 2019. The rising prevalence of atrial fibrillation in the elderly population worldwide primarily drives its market growth. Technological advancement in the minimally invasive percutaneous surgical procedure of left atrial appendage closure devices as an efficient alternative to oral anticoagulants further propels its market growth.
 

Atrial fibrillation is considered the most common type of cardiac arrhythmia encounter in patients with cardiovascular complications which is highly associated with the risk of increased morbidity due to the occurrence of stroke or heart failure. The lack of impulse coordination between the upper and lower chamber of the heart causes the heart to beat either too slowly or quickly causing an irregular heartbeat.

The major segments related to the left atrial appendage closure devices market are: 

By Product Type (2017–2027; US$ Mn)

Endocardial LAA Closure Device

Epicardial LAA Closure Device

By End User (2017–2027; US$ Mn)

Hospital & Clinics

Ambulatory Surgical Centers

Others

Geography Segment (2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA
 

Justification for study?

• The intention of the study is to give a comprehensive outlook of the global Left atrial appendage closure devices market
• The overall segmentation of the left atrial appendage closure devices market, by product type, end-user and geography is minutely studied. Endocardial LAA closure device and hospital & clinics are dominating the product type and end-user segments respectively
• A constant rise in the number of patients suffering from atrial fibrillation worldwide
• Technological advancement in the left atrial appendage closure devices further accentuates its market growth

Report gist?

• The study of the global left atrial appendage closure devices market includes qualitative analysis of factors such as drivers, restraints, and opportunities
• The report covers qualitative and quantitative analysis of the overall market segmented on the basis of product type and end-user and categorization of the same at geography level
• This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

• This study is suitable for industry participants and stakeholders in the medical device manufacturers actively engaged in the production and marketing of Left Atrial Appendage Closure Devices for the surgical treatment of patients suffering from atrial fibrillation worldwide
• The report will benefit researchers engaged in the technological advancement of left atrial appendage closure devices
• Managers with financial institutions looking to publish recent and forecasted statistics pertaining to left atrial appendage closure devices market
• Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Endocardial left atrial appendicular devices are currently representing the largest market share in the product type segment. A significant increase in the number of patients suffering from cardiac stroke associated with atrial fibrillation primarily drives its market growth. Rising demand for minimally invasive percutaneous left atrial appendage closure as an effective alternative for oral anticoagulants for stroke prophylaxis in the patients suffering from non-valvular atrial fibrillation further propels the its market demand. The epicardial LAA closure devices are expected to register excellent market growth in the near future on account of its ability to avoid the need of implanting a permanent device. Additionally there is no need of taking anticoagulant post-surgery procedures of these devices. 

Hospitals and clinics are presently dominating the end-user segment for left atrial appendage closure devices market. Huge investment provided by the government healthcare agencies in providing state of the art medical emergency units and cardiac catheter laboratories primarily drives its market growth. Ambulatory surgical centers are gaining prominence on account of its ability to perform epicardial surgical procedures in patients suffering from atrial fibrillation. 

North America is the clear leader in the geography segment for left atrial appendage closure devices market. As per the latest research citings presented by the American Heart Association (AHA), in 2017 atrial fibrillation was mentioned in the death certificate as the cause of death in approximately 166,793 people in the United States. Additionally the affordable reimbursement scenario for the left atrial appendage closure devices used for the treatment of atrial fibrillation further accentuates its market growth. Europe is presently the 2nd largest regional segment in the left atrial appendage closure devices market. Strategic collaboration between the academic research institutes and medical device manufacturers engaged in the technological advancement of left atrial appendage closure devices primarily drives the market growth in the region. Asia Pacific is anticipated to be the fastest-growing regional segment during the forecast period. Developing healthcare infrastructure and a significant increase in the medical tourism industry together drive the market growth in the Asia Pacific region.